Delivery Order SPE2DB22D3016-SPE2DB25FAYW3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,020.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50ml units. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- AmerisourceBergen Drug Corp was awarded a delivery order for Lidocaine HCL 50ML (25 units) valued at $1,360.90 under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award, issued on August 13, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a contract ceiling value of $1,569.39 and an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on August 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a ceiling value of $1,806.12. This firm fixed-price delivery order, issued on August 27, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is scheduled for ultimate completion by...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lidocaine 2% Viscous in 15 mL unit dose cups. The contract, valued at $3,828.36 with a firm fixed price structure, was competitively awarded without set-aside provisions and is scheduled for completion by September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAYW3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution 4ML on June 10, 2025, with a ceiling value of $1,209.14 and ultimate completion date of June 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office location. This delivery order exemplifies AmerisourceBergen's critical role as a federal pharmaceutical vendor supplying medical commodities to Defense Health Agency and military healthcare systems. The award for lidocaine, a local anesthetic commonly used in military medical and surgical applications, demonstrates the company's ongoing capability to fulfill federal procurement requirements for essential pharmaceutical products. AmerisourceBergen's extensive portfolio of federal contracts with DLA reflects its position as a primary pharmaceutical supply source supporting military readiness and healthcare operations, with the company consistently winning competitive awards across a broad range of therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/10/25 |